Benitec Biopharma Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Benitec Biopharma Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Benitec Biopharma Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $73K, a 7.35% increase year-over-year.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2024 was $275K, a 9.13% increase from 2023.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2023 was $252K, a 28.6% increase from 2022.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2022 was $196K, a 2.08% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $275K +$23K +9.13% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 $252K +$56K +28.6% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 $196K +$4K +2.08% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-21
2021 $192K +$18K +10.3% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 $174K Jul 1, 2019 Jun 30, 2020 10-K 2021-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.